The Protective Effect of (-)-Tetrahydroalstonine against OGD/R-Induced Neuronal Injury via Autophagy Regulation
Molecules · 2023
DOI: 10.3390/molecules28052370 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Yumei Liao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Neuroprotective Agents. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Innovation 2030 Major Projects for "Brain Science and Brain-Inspired Research", National Natural Science Foundation of China, Key-Area Research and Development Program of Guangdong Province.
Abstract (Originalsprache)
Here, (-)-Tetrahydroalstonine (THA) was isolated from Alstonia scholaris and investigated for its neuroprotective effect towards oxygen–glucose deprivation/re-oxygenation (OGD/R)-induced neuronal damage. In this study, primary cortical neurons were pre-treated with THA and then subjected to OGD/R induction. The cell viability was tested by the MTT assay, and the states of the autophagy–lysosomal pathway and Akt/mTOR pathway were monitored by Western blot analysis. The findings suggested that THA administration increased the cell viability of OGD/R-induced cortical neurons. Autophagic activity and lysosomal dysfunction were found at the early stage of OGD/R, which were significantly ameliorated by THA treatment. Meanwhile, the protective effect of THA was significantly reversed by the lysosome inhibitor. Additionally, THA significantly activated the Akt/mTOR pathway, which was suppressed after OGD/R induction. In summary, THA exhibited promising protective effects against OGD/R-induced neuronal injury by autophagy regulation through the Akt/mTOR pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China.
- JNU-HKUST Joint Laboratory for Neuroscience and Innovative Drug Research, College of Pharmacy, Jinan University, Guangzhou 510632, China.
- Guangdong Provincial Engineering Research Center for Modernization of TCM, College of Pharmacy, Jinan University, Guangzhou 510632, China.
- Centro Hospitalar Conde de São Januário, Macau, China.
- NMPA Key Laboratory for Quality Evaluation of TCM, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Xiao-Qi Zhang, Lei Shi, Shiqing Zhang
Förderung
- National Science and Technology Innovation 2030 Major Projects for "Brain Science and Brain-Inspired Research"
- National Natural Science Foundation of China
- Key-Area Research and Development Program of Guangdong Province
- National Key R&D Program of China
- STI2030-Major Projects
- Science and Technology Key Project of Guangdong Province
- Guangdong Basic and Applied Basic Research Foundation
- Science and Technology Planning Project of Guangzhou City
Zitieren
APA
Liao, Y., Wang, J. Y., Pan, Y., Zou, X., Wang, C., Peng, Y., Ao, Y. L., Lam, M. F., Zhang, X., Zhang, X. Q., Shi, L., & Zhang, S. (2023). The Protective Effect of (-)-Tetrahydroalstonine against OGD/R-Induced Neuronal Injury via Autophagy Regulation. Molecules. https://doi.org/10.3390/molecules28052370
Vancouver
Liao Y, Wang JY, Pan Y, Zou X, Wang C, Peng Y, et al. The Protective Effect of (-)-Tetrahydroalstonine against OGD/R-Induced Neuronal Injury via Autophagy Regulation. Molecules. 2023. doi:10.3390/molecules28052370
BibTeX
@article{Liao2023,
author = {Liao, Yumei and Wang, Jun-Ya and Pan, Yan and Zou, Xueyi and Wang, Chaoqun and Peng, Yinghui and Ao, Yun-Lin and Lam, Mei Fong and Zhang, Xiaoshen and Zhang, Xiao-Qi and Shi, Lei and Zhang, Shiqing},
title = {The Protective Effect of (-)-Tetrahydroalstonine against OGD/R-Induced Neuronal Injury via Autophagy Regulation},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052370}
}
EUVIMED